Primary |
Non-small Cell Lung Cancer |
30.0% |
Breast Cancer Metastatic |
20.0% |
Breast Cancer |
10.0% |
Drug Level |
10.0% |
Neoplasm Malignant |
10.0% |
Prophylaxis |
10.0% |
Transitional Cell Carcinoma |
10.0% |
|
Vomiting |
22.2% |
Cardiomyopathy |
11.1% |
Constipation |
11.1% |
Hypoaesthesia |
11.1% |
Sepsis |
11.1% |
Streptococcal Infection |
11.1% |
Urinary Retention |
11.1% |
Urosepsis |
11.1% |
|
Secondary |
Breast Cancer Metastatic |
63.7% |
Breast Cancer |
9.7% |
Drug Use For Unknown Indication |
7.3% |
Prophylaxis |
3.6% |
Neoplasm Malignant |
2.2% |
Pain |
2.2% |
Non-small Cell Lung Cancer |
1.9% |
Abdominal Pain |
1.0% |
Antiemetic Supportive Care |
1.0% |
Depression |
1.0% |
Neoplasm |
1.0% |
Agitation |
0.7% |
Arthralgia |
0.7% |
Metastases To Bone |
0.7% |
Small Cell Lung Cancer Stage Unspecified |
0.7% |
Constipation |
0.5% |
Decreased Appetite |
0.5% |
Drug Level |
0.5% |
Headache |
0.5% |
Insomnia |
0.5% |
|
Thrombocytopenia |
17.3% |
Neutropenia |
12.7% |
Ileus Paralytic |
6.4% |
Lung Infiltration |
5.5% |
Pyelonephritis |
5.5% |
Septic Shock |
5.5% |
Vomiting |
5.5% |
Abdominal Pain |
3.6% |
Arthralgia |
3.6% |
Cellulitis |
3.6% |
Colitis |
3.6% |
Mucosal Inflammation |
3.6% |
Neuralgia |
3.6% |
Ventricular Tachycardia |
3.6% |
Deep Vein Thrombosis |
2.7% |
Hypokalaemia |
2.7% |
Ileus |
2.7% |
Neutropenic Infection |
2.7% |
Pain In Jaw |
2.7% |
Pancytopenia |
2.7% |
|
Concomitant |
Anaemia |
57.1% |
Bone Disorder |
14.3% |
Pain |
14.3% |
Breast Cancer Metastatic |
7.1% |
Epidermal Growth Factor Receptor Increased |
7.1% |
|
Central Line Infection |
20.0% |
Pain |
20.0% |
Renal Failure |
20.0% |
Upper Gastrointestinal Haemorrhage |
20.0% |
Vomiting |
20.0% |
|
Interacting |
Drug Use For Unknown Indication |
50.0% |
Neoplasm Malignant |
50.0% |
|
Neutropenia |
50.0% |
Thrombocytopenia |
50.0% |
|